Nissan Chemical Industries Ltd.
http://www.nissanchem.co.jp
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nissan Chemical Industries Ltd.
Menarini extends rights to Teijin's gout drug febuxostat
Menarini has extended its commercial alliance for Teijin Pharma's gout drug febuxostat to a further 26 mainly emerging markets, acquiring exclusive distribution and marketing rights in Central and South America, the Commonwealth of Independent States and Australia/New Zealand.
BMS Bets On Growth In A Key Emerging Market – Japan
In 2011, Bristol-Myers Squibb stopped a five-year slide in Japan, turning sales into the black for the first time since 2005.
Abbott licenses Kowa's pitavastatin for additional markets
Abbott Laboratories has extended its territorial rights to Kowa's hypolipaemic, pitavastatin, to Australia and New Zealand, where the US firm will exclusively market the product.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice